First Wilshire Securities Management’s Antares Pharma, Inc. ATRS Stock Holding History

First Wilshire Securities Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,799,953	Closed	-$11.5M	–	98
2022 Q1	$11.5M	Buy	2,799,953 +33,512	+1%	+$122K	4.03%	7
2021 Q4	$9.88M	Buy	2,766,441 +112,144	+4%	+$392K	3.08%	10
2021 Q3	$9.66M	Buy	2,654,297 +118,570	+5%	+$479K	3.2%	9
2021 Q2	$11.1M	Buy	+2,535,727	New	+$10.3M	3.87%	6

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Wilshire Securities Management's ATRS Position: Q2 2022 in Review

First Wilshire Securities Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 2,799,953 shares — an estimated $11.5M sold.

First Wilshire Securities Management first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $11.5M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

First Wilshire Securities Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
First Wilshire Securities Management sold 2,799,953 Antares Pharma, Inc. shares in Q2 2022, an estimated $11.5M.
First Wilshire Securities Management first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
First Wilshire Securities Management's Antares Pharma, Inc. position peaked at $11.5M in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on First Wilshire Securities Management's 13F filing for Q2 2022, filed 15 Aug 2022.